A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome
CA 2808592 C · Owner: Beijing Solobio Genetechnology Company Ltd. · Inventors: Li, Yuejuan; Zuo, Conglin; Zhou, Zhiwen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a set of nucleotides against HIV infection and their application for treatment and prevention of AIDS. The sequences of the nucleotides were shown in the sequences table. The invention was superior to the similar technology as following: High conserved RNA sequences were obtained by compare all the published HIV genome sequences. Double strand RNA sequences derived from the sequences can effectively inhibit the expression of target HIV gene. HIV gene expression can also be inhibited by double strand hairpin-like RNA transcribed in the cells harboring recombinant plasmid which contain the DNA sequences encoding the RNA sequences. Further HIV gene expression can be …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 16, 2003 and granted April 28, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 16, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 16, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.